Raymond James Financial’s Achieve Life Sciences ACHV Stock Holding History

Raymond James Financial’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Buy	641,925 +42,246	+7%	+$188K	﹤0.01%	3405
2025 Q4	$2.98M	Buy	599,679 +143,307	+31%	+$625K	﹤0.01%	2936
2025 Q3	$1.44M	Buy	456,372 +161,314	+55%	+$443K	﹤0.01%	3428
2025 Q2	$667K	Buy	295,058 +107,218	+57%	+$305K	﹤0.01%	3827
2025 Q1	$502K	Buy	187,840 +30,321	+19%	+$94.3K	﹤0.01%	3940
2024 Q4	$554K	Buy	+157,519	New	+$714K	﹤0.01%	3845

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Raymond James Financial's ACHV Position: Q1 2026 in Review

Raymond James Financial increased its Achieve Life Sciences (ACHV) stake by 7% in Q1 2026, buying an estimated $188K and bringing the position to 641,925 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

Raymond James Financial first reported a position in ACHV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.98M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Raymond James Financial held 641,925 shares of Achieve Life Sciences worth $1.89M as of Q1 2026.
Raymond James Financial bought 42,246 Achieve Life Sciences shares in Q1 2026, an estimated $188K.
Achieve Life Sciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3405 holding.
Raymond James Financial first reported a position in Achieve Life Sciences in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Achieve Life Sciences position peaked at $2.98M in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.